about
Ocular delivery of macromoleculesMultifunctional PEG retinylamine conjugate provides prolonged protection against retinal degeneration in mice.Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: in vitro and in vivo evaluationDesign and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application.Microrobots: a new era in ocular drug delivery.Gelatin-based particulate systems in ocular drug delivery.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.Established and emerging ancillary techniques in management of microbial keratitis: a review.Nanocrystal for ocular drug delivery: hope or hype.Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone ButyrateAdvances in the use of prodrugs for drug delivery to the eye.Comparison of cytotoxicity in vitro and irritation in vivo for aqueous and oily solutions of surfactants.A comprehensive insight on ocular pharmacokinetics.The diagnosis and management of contact lens-related microbial keratitis.Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy.Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery.Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation.Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part I: influence of process parameters on their preparation studied by experimental design.Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.Preparation and evaluation of HPMC-based pirfenidone solution in vivo.Viscoelastic interactions between polydeoxyribonucleotide and ophthalmic excipients.Mucoadhesive nano-sized supramolecular assemblies for improved pre-corneal drug residence time.Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment.Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
P2860
Q34079676-761751F0-1081-461F-A473-F298F9B71BADQ34669685-DF97C296-05C5-4F3C-AA67-81CFAA2034DCQ35727894-6E90A1BC-4B78-4F88-A707-3CA1CB7F80BBQ35914774-8F5AFE1D-7B74-4AEE-9695-01B78AC9B3E5Q36936716-2B3C1C9C-F95A-4897-B07F-94DC83A23402Q38227020-C87D3DA5-BCF0-4EF5-9FFD-9023054A2434Q38310627-81DD76E2-28E6-47A7-91CF-97230C1675E0Q38584194-60CA0885-046A-429D-BC6E-20822A62E00BQ38714705-95AC9366-F542-4C11-B714-2D1E17C3673EQ38738334-BEBCCBD8-3B10-4926-A1B1-E3DD5B0C0ABBQ38831205-52988896-7DA5-47EF-9DDB-CFBC70E9888DQ38862840-C5CA082B-D7D5-4FAB-9D51-12136BC13C6FQ38904119-6FB71495-7B7F-4BCE-BE1A-3D7F48EA7287Q38975634-647281A9-62F8-48CF-9542-A1F47DD7C828Q38995367-AED953E1-A466-4CC3-9DA7-9F9CADC090F0Q40090439-C71F9C86-5C49-4712-83BF-0C5F8C8DE2C7Q40500729-68F49A0E-65D1-462C-9EE1-A795855E066AQ40573088-155073FE-C97F-4178-894D-E269815DE10CQ41843480-CF004C0C-5877-4720-9604-D657ADC86BAEQ42229593-1BBCACA1-59C5-4F11-9239-9212B542C517Q44774296-F02029EC-6B4E-4673-8BF9-2F091A248077Q47143814-002DBCFB-D45F-49CE-BE88-7687A9F5C96FQ48198477-813AFF2C-758C-469F-A671-A28CEE1FD41AQ49996892-7E2FE8B2-CA4C-43D9-BE9B-5FAE6CA0DCC0Q51824323-8B5AEA00-8B83-4681-9201-3EEEBA5448B4Q53215314-E92431DE-D6DA-4E94-A6F5-14372047C489Q53411665-95C6EBCB-4316-4AF9-A86E-26672B1C97B2Q53577573-AA52D5AA-8C93-41BD-AA15-6FB3CA96B602Q58716234-D82B4468-E9BC-429F-A4C0-38ABF7AD5904
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Recent advances in ocular drug delivery.
@en
type
label
Recent advances in ocular drug delivery.
@en
prefLabel
Recent advances in ocular drug delivery.
@en
P2093
P2860
P1476
Recent advances in ocular drug delivery.
@en
P2093
Djamila Achouri
Kamel Alhanout
Philippe Piccerelle
Véronique Andrieu
P2860
P304
P356
10.3109/03639045.2012.736515
P407
P577
2012-11-16T00:00:00Z